Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AdOmni Supercharges Ads Platform, Launching AI-Driven Self-Serve Campaigns in Minutes
-
Epiq and IRIS Partner to Deliver AI Document Capture and Management
-
Lumanity Launches Expert-Directed AI Platform to Transform Value Demonstration of Life-Changing Medicines
-
zSpace Empowers Educators with zKnow™: AI-Powered Assistant Delivers Instant Answers, Saving Teachers Valuable Time
-
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
-
All Kids Bike and "Mimi and Moto" Creators Collaborate on New Book Encouraging Kids to Ride Bikes
-
Gaxos Labs Launches Art-Gen, an AI Image and Video Creation Platform Targeting Multi-Billion Dollar Market
-
Aptitude Development Expands Partnership with Counslr to Offer 24/7 Mental Health Support Across All Properties Nationwide
-
Interact Launches New Features to Expand Its Industry-Leading Employee Experience Platform
-
Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC
-
bioEnergy Development Announces Bio-Waste Testing Pipeline at Capacity for Q3 2025
-
ICP Securities Inc. Reports Strong Client Performance in First Half of 2025
-
Jerash Holdings to Present at A.G.P.'s Virtual Consumer Showcase on August 25
-
Afinida Revenues Grow 13% - on Pace for Record-Setting Year
-
United States Antimony Announces A New Board Member Appointment of General John M. Keane to Its Board of Directors
-
Optimal Dynamics Expands Customer Success to Power Industry-Wide Transformation
-
Sidoti Events, LLC's Virtual August Micro-Cap Conference
-
VCI Global Announces US$2 Billion Partnership Secured by Sovereign-Grade Encrypted Infrastructure
-
Building Trustworthy AI Starts with Data Confidence, According to Protiviti Study
-
Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)
-
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC
-
More than $2.5 Million Raised at Wisconsin Dells Education Foundation’s 15th Annual Golf for the Future Event
-
Bayport Management Ltd provides a status update
-
Options Expands Private AI Infrastructure with Iceland Data Center Deployment
-
CUPE, Air Canada reach a tentative agreement
-
Bayport Intermediate Holdco PLC provides a status update
-
Cascale Annual Meeting to Challenge Consumer Goods Industry on Climate, Decent Work
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
World Golf Hall of Famer Retief Goosen Joins World Youth Clubs as Global Ambassador
-
Horizon3.ai Appoints Holly Grey as Chief Financial Officer to Drive Scalable Growth and Operational Excellence
-
Sonim Launches XP3plus 5G Ultra-Rugged Flip Phone on AT&T; FirstNet Certified
-
VIQ Solutions Announces Insider Led Private Placement
-
Nevada Sunrise Signs Agreement to Sell the Gemini Lithium Project
-
Romios Announces Closing of Over-Subscribed and Upsized Non-Brokered Offering of $750,000
-
Allied Critical Metals Appoints General James A. "Spider" Marks as a Director of Allied Critical Metals USA, Its U.S. Subsidiary Focused on Tungsten Import and Sales
-
Zefiro Methane Completes First-Ever Sale of Carbon Offsets Originated Under ACR's Orphan Well Methodology
-
Black Swan Graphene and Thomas Swan Announce Expanded Distribution and Sales Agreement
-
Former Nestlé Global Supply Chain Leader Vineet Khanna Joins FourKites' Strategic Advisory Council
-
Final terms for bonds to be listed 20th August 2025
-
FirstService Announces Normal Course Issuer Bid
-
Aveanna to Participate at the Deutsche Bank Healthcare Summit
-
Midland Commences an Exploration Program for Copper-Gold-Molybdenum-Silver Occurrences on the Saruman Project
-
Orezone Intercepts Further High-Grade Mineralization Below Life of Mine Pits Including 1.59 g/t Gold Over 48.00m and 1.09 g/t Gold Over 45.00m
-
ITURAN LOCATION AND CONTROL LTD Announces Dividend Distribution of $10 Million for the Second Quarter of 2025
-
Angitia Biopharmaceuticals to Present Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025
-
Reshoring at Full Speed: Humtown’s 3D Printing Transforms U.S. Manufacturing
-
USA Auto Selects insured.io To Power Their Customer Engagement at Launch
-
Taco Bueno® Selects PAR® Technology to Elevate Restaurant Operations and Scale Growth
-
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer
-
Xtract One Announces Upcoming Investor Events
